Gapping up
In reaction to strong earnings/guidance: NSSC +6.5%, MCHP +6.3%, LUV +1.8%, SSL +0.6%
M&A news: TE +23.8% (to be acquired by Emera for $27.55 per share in cash), CAPN +17.3% (acquires substantially all assets from privately-held NeoForce Group), FCX +6.2% (hired bankers to consider asset sales or cost cuts, according to Bloomberg), ALTR +3.2% (discloses the waiting period under the HSR Act in connection with the proposed acquisition by Intel (INTC) expired on September 4)
Select financial related names showing strength: BCS +4.4%, ING +4%, DB +3.9%, C +3.8%, CS +3.8%, HSBC +3.7%, JPM +2%, BAC +1.9%, MS +1.8%
Select metals/mining stocks trading higher: BHP +3.9%, RIO +3.5%, X +3.1%, SSNI +3.1%, ABX +2%
Select fan favorite names showing strength: GPRO +3.2%, NFLX +3.1%, TSLA +2%, AAPL +2%, TWTR +1.8%
Other news: IMMU +26.5% (reports interim Phase 2 results for sacituzumab govitecan), NSPH +25.2% (receives FDA 510k clearance for its Verigene Respiratory Pathogens Flex Nucleic Acid Test), ABGB +21.6% (cont vol pre-mkt), ASTI +14.3% (agreement to redeem all $21 mln of its senior secured convertible notes from an undisclosed note holder), ICLD +13.1% (secures a new managed services contract valued at $10 mln), ACI +8.1% (attributed to a cautious Bloomberg report on distressed debt deals), TSEM +7.4% (signs agreement with one of its customers to receive $30 mln advance payment), CHK +5.9% (announces new Haynesville and dry gas utica gathering agreements with the Williams Companies (WMB)), JD +5.7% (announces a $1 bln share repurchase program), SUNE +5.3% (installs eight solar systems for India's Delhi Metro Rail Corp), MGIC +4.4% (still checking), BIDU +3.4% (launches a Siri-like online-to-offline personal assistant named Duer for the newest version of its search mobile app), BABA +3.3% (METRO GROUP announced a strategic partnership with Alibaba Group (BABA) to promote business in China), FEYE +3.2% (names new CFO), ARRY +3.2% (new CFO), BMY +2.6% (reports Opdivo showed sustained survival benefit in this patient population, as demonstrated in both CheckMate -017 and -063), GM +2.4% (trading higher with mkt), YHOO +2.3% (in symp with BABA), HTZ +2.2% (Glenview Capital Management discloses 5.2% passive stake in 13G filing), GE +2% (EU set to approve GE acquisiton of Alstom (ALSMY) power unit today, according to WSJ)
Analyst comments: FIT +8% (upgraded to Overweight from Equal-Weight at Morgan Stanley), ACHN +7.2% (upgraded to Buy from Neutral at UBS), W +6.2% (upgraded to Buy from Neutral at BofA/Merrill), SNDK +3.9% (upgraded to Overweight from Neutral at JP Morgan), BP +3.7% (upgraded to Buy from Neutral at UBS), SNY +3.4% (upgraded to Buy from Neutral at UBSI), COT+2.9% (upgraded to Outperform at RBC Capital Mkts), AMGN +2.7% (upgraded to Buy from Neutral at UBS), AA +2.7% (upgraded to Buy from Neutral at BofA/Merrill), REGN +2.4% (upgraded to Buy from Sell at UBS), WFC +2.3% (upgraded to Buy from Hold at Evercore ISI), PG +2.3% (upgraded to Buy from Neutral at Sun Trust Rbsn Humphrey), PHG +2.1% (initiated with a Outperform at Credit Suisse), YUM +2.1% (upgraded to Buy from Outperform at Credit Agricole), BAC +1.9% (upgraded to Buy from Neutral at Nomura), ODP +1.8% (upgraded to Buy from Neutral at B. Riley & Co)
In reaction to strong earnings/guidance: NSSC +6.5%, MCHP +6.3%, LUV +1.8%, SSL +0.6%
M&A news: TE +23.8% (to be acquired by Emera for $27.55 per share in cash), CAPN +17.3% (acquires substantially all assets from privately-held NeoForce Group), FCX +6.2% (hired bankers to consider asset sales or cost cuts, according to Bloomberg), ALTR +3.2% (discloses the waiting period under the HSR Act in connection with the proposed acquisition by Intel (INTC) expired on September 4)
Select financial related names showing strength: BCS +4.4%, ING +4%, DB +3.9%, C +3.8%, CS +3.8%, HSBC +3.7%, JPM +2%, BAC +1.9%, MS +1.8%
Select metals/mining stocks trading higher: BHP +3.9%, RIO +3.5%, X +3.1%, SSNI +3.1%, ABX +2%
Select fan favorite names showing strength: GPRO +3.2%, NFLX +3.1%, TSLA +2%, AAPL +2%, TWTR +1.8%
Other news: IMMU +26.5% (reports interim Phase 2 results for sacituzumab govitecan), NSPH +25.2% (receives FDA 510k clearance for its Verigene Respiratory Pathogens Flex Nucleic Acid Test), ABGB +21.6% (cont vol pre-mkt), ASTI +14.3% (agreement to redeem all $21 mln of its senior secured convertible notes from an undisclosed note holder), ICLD +13.1% (secures a new managed services contract valued at $10 mln), ACI +8.1% (attributed to a cautious Bloomberg report on distressed debt deals), TSEM +7.4% (signs agreement with one of its customers to receive $30 mln advance payment), CHK +5.9% (announces new Haynesville and dry gas utica gathering agreements with the Williams Companies (WMB)), JD +5.7% (announces a $1 bln share repurchase program), SUNE +5.3% (installs eight solar systems for India's Delhi Metro Rail Corp), MGIC +4.4% (still checking), BIDU +3.4% (launches a Siri-like online-to-offline personal assistant named Duer for the newest version of its search mobile app), BABA +3.3% (METRO GROUP announced a strategic partnership with Alibaba Group (BABA) to promote business in China), FEYE +3.2% (names new CFO), ARRY +3.2% (new CFO), BMY +2.6% (reports Opdivo showed sustained survival benefit in this patient population, as demonstrated in both CheckMate -017 and -063), GM +2.4% (trading higher with mkt), YHOO +2.3% (in symp with BABA), HTZ +2.2% (Glenview Capital Management discloses 5.2% passive stake in 13G filing), GE +2% (EU set to approve GE acquisiton of Alstom (ALSMY) power unit today, according to WSJ)
Analyst comments: FIT +8% (upgraded to Overweight from Equal-Weight at Morgan Stanley), ACHN +7.2% (upgraded to Buy from Neutral at UBS), W +6.2% (upgraded to Buy from Neutral at BofA/Merrill), SNDK +3.9% (upgraded to Overweight from Neutral at JP Morgan), BP +3.7% (upgraded to Buy from Neutral at UBS), SNY +3.4% (upgraded to Buy from Neutral at UBSI), COT+2.9% (upgraded to Outperform at RBC Capital Mkts), AMGN +2.7% (upgraded to Buy from Neutral at UBS), AA +2.7% (upgraded to Buy from Neutral at BofA/Merrill), REGN +2.4% (upgraded to Buy from Sell at UBS), WFC +2.3% (upgraded to Buy from Hold at Evercore ISI), PG +2.3% (upgraded to Buy from Neutral at Sun Trust Rbsn Humphrey), PHG +2.1% (initiated with a Outperform at Credit Suisse), YUM +2.1% (upgraded to Buy from Outperform at Credit Agricole), BAC +1.9% (upgraded to Buy from Neutral at Nomura), ODP +1.8% (upgraded to Buy from Neutral at B. Riley & Co)